Enzene Biosciences inaugurates R&D Center with open lab setup in Pune
The new R&D centre signals strategic growth plans, expanded capabilities and enhanced services
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
CDMO
JB Pharma: Betting big on India
Our biggest bet is India and the CDMO space, says Nikhil Chopra, CEO, JB Pharma, taking stock of the company's ongoing transition…
Baxter to divest biopharma solutions business to Advent International and Warburg Pincus for $4.25…
Net proceeds planned to be redeployed for debt repayment in accordance with Baxter’s stated capital allocation priorities
Enzene Biosciences raises $50 million to boost manufacturing capabilities and grow in global markets
The funding round is led by Alkem Laboratories and new investors, Eight Roads Ventures and F-Prime Capital
We will maintain a growth rate in the high teens for both (CDMO and API business) in the next few…
In a recent interaction, Manoj Mehrotra, President Pharmaceuticals, Hikal explains to Viveka Roychowdhury how Hikal's plans to be…
Pharma leaders network at PHARMAP 2022
The two-day business programme included networking and interaction among representatives of the pharma industry, panel…
Piramal Pharma Solutions expands in-vitro biology capabilities at Ahmedabad Discovery Services Site
The benefits of this new investment will be seen in an improved experience for PPS discovery services customers
Piramal Pharma invests Rs 101.77 crores in Hyderabad-based Yapan Bio
The Mumbai-based company has acquired a 27.78 per cent stake in Yapan as a result of the investment
WuXi STA forms strategic partnership with Coherent Biopharma
According to the agreement, WuXi STA will become the preferred CDMO partner and provide Coherent Biopharma with integrated CMC…
The future CRO/CDMO will offer end-to-end solutions and operate as a large pharma or biotech company
Dr Mahesh Bhalgat, COO, Syngene talks about his company's outlook, investments and capacity expansion, as well as Syngene's plans…